Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

Author(s): Hans Carl Hasselbalch

Volume 12, Issue 3, 2011

Page: [387 - 391] Pages: 5

DOI: 10.2174/138945011794815220

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

28

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

The Possible Use of Terpene Compounds in DC Immunotherapy against Cancer
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Current Drug Targets

Monocyte Dependent Regulation of Autoimmune Inflammation
Current Molecular Medicine

Chromosomal Translocations as Biomarkers in Leukemia Diagnosis and Pharmacogenomics
Recent Patents on Biomarkers

Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics

Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
Current Cancer Drug Targets

Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
Current Cancer Drug Targets

Aromatase Inhibitors: A New Paradigm in Breast Cancer Treatment
Current Medicinal Chemistry - Anti-Cancer Agents

Drug Resistance: Challenges to Effective Therapy
Current Cancer Drug Targets

Targeting p73 - a Potential Approach in Cancer Treatment
Current Pharmaceutical Design

Targeted Radionuclide Therapy - An Overview
Current Radiopharmaceuticals

Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression
Current Protein & Peptide Science

Chronic Immune Stimulation Correlates with Reduced Phenylalanine Turnover
Current Drug Metabolism

Pharmacotherapy of Schizophrenia: The Past, Present and Future
Current Drug Therapy

Multidisciplinary Treatment of Early Stage Endometrial Cancer
Anti-Cancer Agents in Medicinal Chemistry

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
Anti-Cancer Agents in Medicinal Chemistry

Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics
Current Pharmaceutical Design

Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
Current Pharmaceutical Design

Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets

Cancer Regulator MicroRNA: Potential Relevance in Diagnosis, Prognosis and Treatment of Cancer
Current Medicinal Chemistry

© 2024 Bentham Science Publishers | Privacy Policy